BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 14720059)

  • 1. Idiopathic pulmonary fibrosis: current and future treatment options.
    Davies HR; Richeldi L
    Am J Respir Med; 2002; 1(3):211-24. PubMed ID: 14720059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunomodulatory agents for idiopathic pulmonary fibrosis.
    Davies HR; Richeldi L; Walters EH
    Cochrane Database Syst Rev; 2003; (3):CD003134. PubMed ID: 12917947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current and future treatment options in idiopathic pulmonary fibrosis.
    Hauber HP; Blaukovitsch M
    Inflamm Allergy Drug Targets; 2010 Jul; 9(3):158-72. PubMed ID: 20518722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of pulmonary fibrosis].
    Cottin V
    Presse Med; 2002 Oct; 31(34):1613-23. PubMed ID: 12426980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current and future therapeutic approaches in idiopathic pulmonary fibrosis.
    Bouros D; Antoniou KM
    Eur Respir J; 2005 Oct; 26(4):693-702. PubMed ID: 16204603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novelty in treatment of pulmonary fibrosis: pulmonary hypertension drugs and others.
    Correale M; Totaro A; Lacedonia D; Montrone D; Di Biase M; Barbaro Foschino MP; Brunetti ND
    Cardiovasc Hematol Agents Med Chem; 2013 Sep; 11(3):169-78. PubMed ID: 24011020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current perspectives on the treatment of idiopathic pulmonary fibrosis.
    Walter N; Collard HR; King TE
    Proc Am Thorac Soc; 2006 Jun; 3(4):330-8. PubMed ID: 16738197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corticosteroid and immunomodulatory agents in idiopathic pulmonary fibrosis.
    Luppi F; Cerri S; Beghè B; Fabbri LM; Richeldi L
    Respir Med; 2004 Nov; 98(11):1035-44. PubMed ID: 15526803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pulmonary fibrosis--a therapeutic dilemma?].
    Günther A; Markart P; Eickelberg O; Seeger W
    Med Klin (Munich); 2006 Apr; 101(4):308-12. PubMed ID: 16607487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Drug treatments for idiopathic pulmonary fibrosis].
    Crestani B; Marchand-Adam S; Schneider S
    Rev Pneumol Clin; 2005 Jun; 61(3):221-31. PubMed ID: 16142196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-steroid agents for idiopathic pulmonary fibrosis.
    Spagnolo P; Del Giovane C; Luppi F; Cerri S; Balduzzi S; Walters EH; D'Amico R; Richeldi L
    Cochrane Database Syst Rev; 2010 Sep; (9):CD003134. PubMed ID: 20824834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of idiopathic pulmonary fibrosis: is there anything new?
    Abdelaziz MM; Samman YS; Wali SO; Hamad MM
    Respirology; 2005 Jun; 10(3):284-9. PubMed ID: 15955138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corticosteroids for idiopathic pulmonary fibrosis.
    Richeldi L; Davies HR; Ferrara G; Franco F
    Cochrane Database Syst Rev; 2003; 2003(3):CD002880. PubMed ID: 12917934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Idiopathic pulmonary fibrosis.
    Balamugesh T; Behera D
    J Assoc Physicians India; 2007 May; 55():363-70. PubMed ID: 17844698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppressive drug therapy.
    McCune WJ; Vallance DK; Lynch JP
    Curr Opin Rheumatol; 1994 May; 6(3):262-72. PubMed ID: 8060760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The evolving pharmacotherapy of pulmonary fibrosis.
    Lota HK; Wells AU
    Expert Opin Pharmacother; 2013 Jan; 14(1):79-89. PubMed ID: 23265249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study protocol: exploring the efficacy of cyclophosphamide added to corticosteroids for treating acute exacerbation of idiopathic pulmonary fibrosis; a randomized double-blind, placebo-controlled, multi-center phase III trial (EXAFIP).
    Naccache JM; Montil M; Cadranel J; Cachanado M; Cottin V; Crestani B; Valeyre D; Wallaert B; Simon T; Nunes H
    BMC Pulm Med; 2019 Apr; 19(1):75. PubMed ID: 30971235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of antifibrotic agents on TGF-beta1, CTGF and IFN-gamma expression in patients with idiopathic pulmonary fibrosis.
    Tzortzaki EG; Antoniou KM; Zervou MI; Lambiri I; Koutsopoulos A; Tzanakis N; Plataki M; Maltezakis G; Bouros D; Siafakas NM
    Respir Med; 2007 Aug; 101(8):1821-9. PubMed ID: 17391951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Idiopathic pulmonary fibrosis: pathogenesis and therapeutic approaches.
    Selman M; Thannickal VJ; Pardo A; Zisman DA; Martinez FJ; Lynch JP
    Drugs; 2004; 64(4):405-30. PubMed ID: 14969575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recognition and treatment of idiopathic pulmonary fibrosis.
    Nicod LP
    Drugs; 1998 Apr; 55(4):555-62. PubMed ID: 9561344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.